Regulating effect of liraglutide therapy on metabolic disorders in patients with newly diagnosed type 2 diabetes complicated with obesity

Regulating effect of liraglutide therapy on metabolic disorders in patients with newly diagnosed type 2 diabetes complicated with obesity

Objective: To investigate the regulating effect of liraglutide therapy on metabolic disorders in patients with newly diagnosed type 2 diabetes complicated with obesity. Methods: A total of 118 patients with newly diagnosed type 2 diabetes complicated with obesity who were treated in the hospital...

Full description

Bibliographic Details
Main Authors:	Dong-Mei Gao, Shan-Dan Bao
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2017-08-01
Series:	Journal of Hainan Medical University
Subjects:	Type 2 diabetes mellitus Obesity Liraglutide Lipid metabolism Inflammatory response
Online Access:	http://www.hnykdxxb.com/PDF/201716/10.pdf

Similar Items

Effect of liraglutide and metformin on constitution, metabolism and micro-inflammatory state in newly diagnosed type 2 diabetic mellitus patients with obesity
by: Xiu-Ping Han, et al.
Published: (2016-08-01)

Efficacy of Liraglutide Application in Patients with Diabetes Mellitus Type 2 and Obesity in Real Clinical Practice (Literature Review the and Findings of Our Own Observations)
by: V.I. Pankiv
Published: (2014-09-01)

Effect of liraglutide combined with basal insulin on blood glucose control, lipid metabolism and oxidative stress in patients with newly diagnosed type 2 diabetes mellitus complicated by obesity
by: Fei-Fei He, et al.
Published: (2018-02-01)

Efficacy and safety of liraglutide in Indian adolescents with obesity
by: I. S. Kochar, et al.
Published: (2019-06-01)

Effects of liraglutide on metabolic syndrome in WBN/Kob diabetic fatty rats supplemented with a high‐fat diet
by: Noriyuki Kaji, et al.
Published: (2020-03-01)

Clinical Impact of Liraglutide as a Treatment of Obesity
by: Alruwaili H, et al.
Published: (2021-03-01)

Feasibility, Adherence and Efficacy of Liraglutide Treatment in a Sample of Individuals With Mood Disorders and Obesity
by: Alessandro Cuomo, et al.
Published: (2019-01-01)

Case Report: Liraglutide for Weight Management in Beckwith-Wiedemann Syndromic Obesity
by: Marina Caputo, et al.
Published: (2021-06-01)

Effects of liraglutide combined with metformin on lipid metabolism and micro-inflammatory response in T2DM patients with obesity
by: Wei-Huan Zhang, et al.
Published: (2018-08-01)

Liraglutide overdose: A case report and an updated review
by: Sharafaldeen Bin Nafisah, et al.
Published: (2020-01-01)

Effects of liraglutide on obesity-associated functional hypogonadism in men
by: M Jensterle, et al.
Published: (2019-02-01)

Liraglutide and the management of overweight and obesity in people with schizophrenia, schizoaffective disorder and first-episode psychosis: protocol for a pilot trial
by: Clare Alexandra Whicher, et al.
Published: (2019-11-01)

Long-term efficacy of liraglutide in Indian patients with Type 2 diabetes in a real-world setting
by: Parjeet Kaur, et al.
Published: (2016-01-01)

Successful rapid weight reduction and the use of liraglutide for morbid obesity in adolescent Prader-Willi syndrome
by: Yoo-Mi Kim, et al.
Published: (2020-03-01)

Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
by: Vladimir Ivanovich Kudinov, et al.
Published: (2011-06-01)

The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg
by: Marcio C. Mancini, et al.
Published: (2017-05-01)

Adropin – Potential Link in Cardiovascular Protection for Obese Male Type 2 Diabetes Mellitus Patients Treated with Liraglutide
by: Tina Tičinović Kurir, et al.
Published: (2020-01-01)

Prediction of early response to liraglutide therapy in patients with obesity
by: Oksana V. Logvinova, et al.
Published: (2020-06-01)

First GLP-1 analog liraglutide: the result of clinical trails on efficacy
by: Alexander Sergeevich Ametov, et al.
Published: (2011-12-01)

Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada
by: Sean Wharton, et al.
Published: (2020-08-01)

Continuation of Liraglutide during Fasting is not Associated with Hypoglycaemia
by: Rosalie Koot, et al.
Published: (2017-10-01)

Gglucagon-like peptide-1 analogue liraglutide (Saxenda®): mechanism of action, efficacy for the treatment of obesity
by: Tatiana I. Romantsova
Published: (2018-04-01)

Comparison of Efficacy and Safety of Liraglutide 3.0 mg in Individuals with BMI above and below 35 kg/m²: A Post-hoc Analysis
by: Carel le Roux, et al.
Published: (2017-11-01)

The Effects of Liraglutide on In Vitro Fertilization in Mice Following Experimental Diabetes
by: Rafieh Khalily, et al.
Published: (2020-03-01)

The Discovery and Development of Liraglutide and Semaglutide
by: Lotte Bjerre Knudsen, et al.
Published: (2019-04-01)

Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
by: Young-Gyun Seo
Published: (2021-03-01)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01)

Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
by: Li Chun-jun, et al.
Published: (2012-11-01)

Thromboxane-Dependent Platelet Activation in Obese Subjects with Prediabetes or Early Type 2 Diabetes: Effects of Liraglutide- or Lifestyle Changes-Induced Weight Loss
by: Paola Simeone, et al.
Published: (2018-12-01)

LIRAGLUTIDE: SUCESSO NO TRATAMENTO DO DIABETES MELLITUS EM MONOTERAPIA E ASSOCIAÇÕES – REVISÃO SISTEMÁTICA
by: George Robson Ibiapina, et al.
Published: (2011-12-01)

Efficacy of liraglutide 3 mig therapy in obesity and associated diseases
by: K. A. Komshilova, et al.
Published: (2018-03-01)

Short-term monotherapy with Liraglutide for weight management: A case study
by: Feras Almarshad
Published: (2019-01-01)

Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes
by: Inoue Kana, et al.
Published: (2011-12-01)

Short-term treatment with high dose liraglutide improves lipid and lipoprotein profile and changes hormonal mediators of lipid metabolism in obese patients with no overt type 2 diabetes mellitus: a randomized, placebo-controlled, cross-over, double-blind clinical trial
by: Natia Peradze, et al.
Published: (2019-10-01)

Liraglutide Improves Non-Alcoholic Fatty Liver Disease In Diabetic Mice By Modulating Inflammatory Signaling Pathways
by: Luo Y, et al.
Published: (2019-12-01)

Effects of liraglutide on lipolysis and the AC3/PKA/HSL pathway
by: Li Z, et al.
Published: (2019-09-01)

EARLY EXPERIENCE OF GPP-1 LIRAGLUTIDE 3.0 MG ANALOGUE IN RUSSIA AND ITS EFFECT ON METABOLIC RISK FACTORS IN OBESITY PATIENTS
by: K. A. Komshilova, et al.
Published: (2017-12-01)

Liraglutide Ameliorates Erectile Dysfunction via Regulating Oxidative Stress, the RhoA/ROCK Pathway and Autophagy in Diabetes Mellitus
by: Penghui Yuan, et al.
Published: (2020-08-01)

A review of the efficacy and safety of the finished fixed-ratio combination of insulin degludec and liraglutide in the treatment of type 2 diabetes mellitus
by: A. S. Pogorelova
Published: (2018-07-01)

Clinical and psychological characteristics of liraglutide treatment among patients with type 2 diabetes
by: Ayman A Al Hayek, et al.
Published: (2020-01-01)